Company: BNBX
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001410578-25-001320
Chunk: 3

Company: BNB PLUS CORP.
Filing Date: 2025-05-15
Form: 10-Q
Item: Part I, Item 1F
Chunk 3
---
 DNA Sciences, Inc. stockholders’ equity:​   ​   Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of March 31, 2025 and September 30, 2024​  —​  —Series A Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- issued and outstanding as of March 31, 2025 and September 30, 2024​  —​  —Series B Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- issued and outstanding as of March 31, 2025 and September 30, 2024​  —​  —​​​ ​​​​Common stock, par value $0.001 per share; 200,000,000 shares authorized as of March 31, 2025 and September 30, 2024; 6,331,410 and 206,324 shares issued and outstanding as of March 31, 2025 and September 30, 2024, respectively​  6,331​  206Additional paid in capital ​  364,896,649​  318,815,166Accumulated deficit ​  (354,442,994)​  (309,672,755)Applied DNA Sciences, Inc. stockholders’ equity​  10,459,986​  9,142,617Noncontrolling interest​​ (235,778)​​ (174,532)Total equity​​ 10,224,208​​ 8,968,085 ​​​​​​​Total liabilities and equity​$ 13,035,663​$ 12,789,040

​

See the accompanying notes to the unaudited condensed consolidated financial statements

​